catechin has been researched along with Encapsulating Peritoneal Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Jiang, Y; Liu, C; Pu, X; Zeng, N; Zhang, L | 1 |
| Furusu, A; Hishikawa, Y; Kitamura, M; Kohno, S; Koji, T; Nishino, T; Obata, Y | 1 |
2 other study(ies) available for catechin and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Epigallocatechin gallate prevents peritoneal fibrosis by inhibiting epithelial-mesenchymal transition in human peritoneal mesothelial cells.
Topics: Cadherins; Catechin; Epithelial-Mesenchymal Transition; Humans; Peritoneal Fibrosis | 2022 |
Epigallocatechin gallate suppresses peritoneal fibrosis in mice.
Topics: Animals; Catechin; Chemokine CCL2; Dialysis Solutions; Inflammation; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; NF-kappa B; Peritoneal Fibrosis; Peritoneum; Platelet Endothelial Cell Adhesion Molecule-1; Pyruvaldehyde; Reactive Oxygen Species; Vascular Endothelial Growth Factor A | 2012 |